These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 16431924)
1. Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1. Zheng PS; Reis M; Sparling C; Lee DY; La Pierre DP; Wong CK; Deng Z; Kahai S; Wen J; Yang BB J Biol Chem; 2006 Mar; 281(12):8175-82. PubMed ID: 16431924 [TBL] [Abstract][Full Text] [Related]
2. Identification of the motif in versican G3 domain that plays a dominant-negative effect on astrocytoma cell proliferation through inhibiting versican secretion and binding. Wu Y; Zhang Y; Cao L; Chen L; Lee V; Zheng PS; Kiani C; Adams ME; Ang LC; Paiwand F; Yang BB J Biol Chem; 2001 Apr; 276(17):14178-86. PubMed ID: 11297534 [TBL] [Abstract][Full Text] [Related]
3. Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro. Yang BL; Yang BB; Erwin M; Ang LC; Finkelstein J; Yee AJ Life Sci; 2003 Nov; 73(26):3399-413. PubMed ID: 14572881 [TBL] [Abstract][Full Text] [Related]
4. The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. Zhang Y; Cao L; Yang BL; Yang BB J Biol Chem; 1998 Aug; 273(33):21342-51. PubMed ID: 9694895 [TBL] [Abstract][Full Text] [Related]
5. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. Zheng PS; Wen J; Ang LC; Sheng W; Viloria-Petit A; Wang Y; Wu Y; Kerbel RS; Yang BB FASEB J; 2004 Apr; 18(6):754-6. PubMed ID: 14766798 [TBL] [Abstract][Full Text] [Related]
6. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Sheng W; Wang G; Wang Y; Liang J; Wen J; Zheng PS; Wu Y; Lee V; Slingerland J; Dumont D; Yang BB Mol Biol Cell; 2005 Mar; 16(3):1330-40. PubMed ID: 15635104 [TBL] [Abstract][Full Text] [Related]
7. Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor. Xiang YY; Dong H; Wan Y; Li J; Yee A; Yang BB; Lu WY J Biol Chem; 2006 Jul; 281(28):19358-68. PubMed ID: 16648628 [TBL] [Abstract][Full Text] [Related]
8. The G3 domain of versican inhibits mesenchymal chondrogenesis via the epidermal growth factor-like motifs. Zhang Y; Cao L; Kiani CG; Yang BL; Yang BB J Biol Chem; 1998 Dec; 273(49):33054-63. PubMed ID: 9830060 [TBL] [Abstract][Full Text] [Related]
9. Tandem repeats are involved in G1 domain inhibition of versican expression and secretion and the G3 domain enhances glycosaminoglycan modification and product secretion via the complement-binding protein-like motif. Yang BL; Cao L; Kiani C; Lee V; Zhang Y; Adams ME; Yang BB J Biol Chem; 2000 Jul; 275(28):21255-61. PubMed ID: 10801813 [TBL] [Abstract][Full Text] [Related]
10. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. Ang LC; Zhang Y; Cao L; Yang BL; Young B; Kiani C; Lee V; Allan K; Yang BB J Neuropathol Exp Neurol; 1999 Jun; 58(6):597-605. PubMed ID: 10374750 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin. Wu Y; Chen L; Cao L; Sheng W; Yang BB J Cell Sci; 2004 May; 117(Pt 11):2227-37. PubMed ID: 15126624 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation. Lee V; Chen L; Paiwand F; Cao L; Wu Y; Inman R; Adams ME; Yang BB J Biol Chem; 2002 Jun; 277(25):22279-88. PubMed ID: 11932252 [TBL] [Abstract][Full Text] [Related]
13. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. Zheng PS; Vais D; Lapierre D; Liang YY; Lee V; Yang BL; Yang BB J Cell Sci; 2004 Nov; 117(Pt 24):5887-95. PubMed ID: 15522894 [TBL] [Abstract][Full Text] [Related]
14. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. Cattaruzza S; Schiappacassi M; Kimata K; Colombatti A; Perris R FASEB J; 2004 Apr; 18(6):779-81. PubMed ID: 14977887 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells. Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231 [TBL] [Abstract][Full Text] [Related]
16. beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. Wu Y; Chen L; Zheng PS; Yang BB J Biol Chem; 2002 Apr; 277(14):12294-301. PubMed ID: 11805102 [TBL] [Abstract][Full Text] [Related]
17. Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation. Kamiya N; Watanabe H; Habuchi H; Takagi H; Shinomura T; Shimizu K; Kimata K J Biol Chem; 2006 Jan; 281(4):2390-400. PubMed ID: 16257955 [TBL] [Abstract][Full Text] [Related]
18. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123 [TBL] [Abstract][Full Text] [Related]
19. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. Kawashima H; Hirose M; Hirose J; Nagakubo D; Plaas AH; Miyasaka M J Biol Chem; 2000 Nov; 275(45):35448-56. PubMed ID: 10950950 [TBL] [Abstract][Full Text] [Related]
20. Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3. Zhang Y; Wu Y; Cao L; Lee V; Chen L; Lin Z; Kiani C; Adams ME; Yang BB Exp Cell Res; 2001 Feb; 263(1):33-42. PubMed ID: 11161703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]